Company Filing History:
Years Active: 2004-2005
Title: Innovations in Proton Beam Therapy by D Douglas Miller
Introduction
D Douglas Miller is a notable inventor based in St. Louis, MO (US). He has made significant contributions to the field of medical technology, particularly in the area of proton beam therapy. With a total of 2 patents, his work focuses on enhancing the precision and effectiveness of radiotherapy.
Latest Patents
Miller's latest patents include a "Method for combining proton beam irradiation and magnetic resonance imaging" and a "System combining proton beam irradiation and magnetic resonance imaging." Both inventions aim to coordinate proton beam irradiation with an open magnetic resonance imaging (MRI) unit. This innovative approach allows for near-simultaneous, noninvasive localization and radiotherapy of various cell lines in different anatomical locations. The method utilizes a reference image of the target to aid in treatment planning and patient repositioning within the MRI unit. The patient is positioned so that the target and the proton beam are coincident, with MRI monitoring the target's location. Target irradiation occurs when the target and the proton beam align, as indicated by the MRI. The process involves patient rotation relative to the radiation source, with continuous monitoring and selective irradiation according to the treatment plan.
Career Highlights
Miller is affiliated with Saint Louis University, where he contributes to research and development in medical technologies. His work has been instrumental in advancing the field of proton therapy, making it safer and more effective for patients.
Collaborations
Miller collaborates with Richard D Bucholz, a fellow professional in the field. Their partnership enhances the research and development efforts at Saint Louis University, leading to innovative solutions in medical imaging and treatment.
Conclusion
D Douglas Miller's contributions to proton beam therapy represent a significant advancement in medical technology. His innovative patents and collaborative efforts continue to shape the future of radiotherapy, improving patient outcomes.